Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « outcome »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
outburst < outcome < outcomes  Facettes :

List of bibliographic references indexed by outcome

Number of relevant bibliographic references: 107.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000016 (2021) Claudia Lilli ; Annibale Biggeri [Italie] ; Chiara Zingaretti ; Bernadette Vertogen ; Valeria Frassineti ; Roberto Vespignani ; Veruska Grossi ; Caterina Florescu ; Laura Matteucci ; Chiara Pazzi ; Alberto Bongiovanni ; Francesco Limarzi ; Valentina Fausti ; Lucia Bertoni ; Caterina Donati ; Francesca Galardi ; Nicola Gentili ; Francesco Mazza ; Giovanni Martinelli ; Oriana NanniIs it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine.
000043 (2021) Albert Prats-Uribe [Royaume-Uni] ; Anthony G. Sena [États-Unis, Pays-Bas] ; Lana Yin Hui Lai [Royaume-Uni] ; Waheed-Ul-Rahman Ahmed [Royaume-Uni] ; Heba Alghoul ; Osaid Alser [États-Unis] ; Thamir M. Alshammari [Arabie saoudite] ; Carlos Areia [Royaume-Uni] ; William Carter [États-Unis] ; Paula Casajust [Espagne] ; Dalia Dawoud [Égypte, Royaume-Uni] ; Asieh Golozar [États-Unis] ; Jitendra Jonnagaddala [Australie] ; Paras P. Mehta [États-Unis] ; Mengchun Gong [République populaire de Chine] ; Daniel R. Morales [Royaume-Uni, Danemark] ; Fredrik Nyberg [Suède] ; Jose D. Posada [États-Unis] ; Martina Recalde [Espagne] ; Elena Roel [Espagne] ; Karishma Shah [Royaume-Uni] ; Nigam H. Shah [États-Unis] ; Lisa M. Schilling [États-Unis] ; Vignesh Subbian [États-Unis] ; David Vizcaya [Espagne] ; Lin Zhang [République populaire de Chine, Australie] ; Ying Zhang [République populaire de Chine] ; Hong Zhu [République populaire de Chine] ; Li Liu [République populaire de Chine] ; Jaehyeong Cho [Corée du Sud] ; Kristine E. Lynch [États-Unis] ; Michael E. Matheny [États-Unis] ; Seng Chan You [Corée du Sud] ; Peter R. Rijnbeek [Pays-Bas] ; George Hripcsak [États-Unis] ; Jennifer Ce Lane [Royaume-Uni] ; Edward Burn [Royaume-Uni, Espagne] ; Christian Reich [États-Unis] ; Marc A. Suchard [États-Unis] ; Talita Duarte-Salles [Espagne] ; Kristin Kostka [États-Unis] ; Patrick B. Ryan [Slovénie, États-Unis] ; Daniel Prieto-Alhambra [Royaume-Uni]Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
000077 (2021) Muhammad Sani Ismaila [Trinité-et-Tobago] ; Faruku Bande [Nigeria] ; Aminu Ishaka [Nigeria] ; Aminatu Abubakar Sani [Nigeria] ; Karla Georges [Trinité-et-Tobago]Therapeutic options for COVID-19: a quick review.
000084 (2021) Bhanu Prasad Venkatesulu [États-Unis] ; Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Prashanth Giridhar [Inde] ; Pragathee V [Inde] ; Harsh K. Patel [États-Unis] ; Jacob Manteuffel [États-Unis]The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review.
000091 (2021) Fatemeh Sadat Hosseini [Iran] ; Alireza Malektojari [Iran] ; Sara Ghazizadeh [Iran] ; Mehdi Hassaniazad [Iran] ; Parivash Davoodian [Iran] ; Habib Dadvand [Iran] ; Amin Reza Nikpoor [Iran] ; Sara Nikoofal-Sahlabadi [Iran] ; Sara Kahoori [Iran] ; Mojtaba Sepandi [Iran] ; Soheil Hassanipour [Iran] ; Mohammad Fathalipour [Iran]The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
000099 (2021) Zelyn Lee [Canada] ; Craig R. Rayner [États-Unis, Australie] ; Jamie I. Forrest [Canada] ; Jean B. Nachega [Afrique du Sud, États-Unis, Canada] ; Esha Senchaudhuri [Canada] ; Edward J. Mills [Canada]The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.
000114 (2021) Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis]Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.
000180 (2021) Ilad Alavi Darazam [Iran] ; Shervin Shokouhi [Iran] ; Mohamad Amin Pourhoseingholi [Iran] ; Seyed Sina Naghibi Irvani [Iran] ; Majid Mokhtari [Iran] ; Minoosh Shabani [Iran] ; Mahdi Amirdosara [Iran] ; Parham Torabinavid [Iran] ; Maryam Golmohammadi [Iran] ; Sayedpayam Hashemi [Iran] ; Arsalan Azimi [Iran] ; Mohammad Hossein Jafarazadeh Maivan [Iran] ; Omidvar Rezaei [Iran] ; Alireza Zali [Iran] ; Mohammadreza Hajiesmaeili [Iran] ; Hadiseh Shabanpour Dehbsneh [Iran] ; Akram Hoseyni Kusha [Iran] ; Maryam Taleb Shoushtari [Iran] ; Negar Khalili [Iran] ; Azam Soleymaninia [Iran] ; Latif Gachkar [Iran] ; Ali Khoshkar [Iran]Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial.
000185 (2021) Sonsoles Salto-Alejandre [Espagne] ; Silvia Jiménez-Jorge [Espagne] ; Nuria Sabé [Espagne] ; Antonio Ramos-Martínez [Espagne] ; Laura Linares [Espagne] ; Maricela Valerio [Espagne] ; Pilar Martín-Dávila [Espagne] ; Mario Fernández-Ruiz [Espagne] ; María Carmen Fari As [Espagne] ; Marino Blanes-Juliá [Espagne] ; Elisa Vidal [Espagne] ; Zaira R. Palacios-Baena [Espagne] ; Román Hernández-Gallego [Espagne] ; Jordi Carratalá [Espagne] ; Jorge Calder N-Parra [Espagne] ; María Ángeles Marcos [Espagne] ; Patricia Mu Oz [Espagne] ; Jesús Fortún-Abete [Espagne] ; José María Aguado [Espagne] ; Francisco Arnaiz-Revillas [Espagne] ; Rosa Blanes-Hernández [Espagne] ; Julián De La Torre-Cisneros [Espagne] ; Luis E. L Pez-Cortés [Espagne] ; Elena García De Vinuesa-Calvo [Espagne] ; Clara M. Rosso [Espagne] ; Jer Nimo Pach N [Espagne] ; Javier Sánchez-Céspedes [Espagne] ; Elisa Cordero [Espagne]Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study.
000290 (2021) Nursel Çal K Ba Aran [Turquie] ; O Uz Abdullah Uyaro Lu [Turquie] ; Gülçin Telli Dizman [Turquie] ; Lale Öz K [Turquie] ; Taha Koray Ahin [Turquie] ; Zahit Ta [Turquie] ; Ahmet Ça Kan Nkaya [Turquie] ; Sevilay Karahan [Turquie] ; Ehnaz Alp [Turquie] ; Alpaslan Alp [Turquie] ; Gökhan Metan [Turquie] ; P Nar Zarakol [Turquie] ; Gülay Sain Güven [Turquie] ; Erife Gül Öz [Turquie] ; Arzu Topeli [Turquie] ; Ömrüm Uzun [Turquie] ; Murat Akova [Turquie] ; Serhat Ünal [Turquie]Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU
000345 (2021) Claudia Musial [Pologne] ; Magdalena Gorska-Ponikowska [Pologne]Medical progress: Stem cells as a new therapeutic strategy for COVID-19.
000407 (2021) Anca Pantea Stoian [Roumanie] ; Doina Catrinoiu [Roumanie] ; Manfredi Rizzo [États-Unis, Italie] ; Antonio Ceriello [Italie]Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story.
000452 (2021) Abdulrhman Mohana [Arabie saoudite] ; Tarek Sulaiman [Arabie saoudite] ; Nagla Mahmoud [Arabie saoudite] ; Mustafa Hassanein [Arabie saoudite] ; Amel Alfaifi [Arabie saoudite] ; Eissa Alenazi [Arabie saoudite] ; Nashwa Radwan [Arabie saoudite] ; Nasser Alkhalifah [Arabie saoudite] ; Ehab Elkady [Arabie saoudite] ; Abdullah Almohaizeie [Arabie saoudite] ; Fouad Abogazalah [Arabie saoudite] ; Khaled Alabdulkareem [Arabie saoudite] ; Fahad Alghofaili [Arabie saoudite] ; Hani Jokdar [Arabie saoudite] ; Fahad Alrabiah [Arabie saoudite]Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia.
000484 (2021) Cristian Quintana-Ortega [Espagne] ; Agustín Remesal [Espagne] ; Marta Ruiz De Valbuena [Espagne] ; Olga De La Serna [Espagne] ; María Laplaza-González [Espagne] ; Elena Álvarez-Rojas [Espagne] ; Clara Udaondo [Espagne] ; Rosa Alcobendas [Espagne] ; Sara Murias [Espagne]Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
000496 (2021) Eun Ji Kim [États-Unis] ; Kevin Coppa [États-Unis] ; Jamie S. Hirsch [États-Unis] ; Sara Abrahams [États-Unis] ; Jennifer Johnson [États-Unis] ; Martin Lesser [États-Unis] ; Karina W. Davidson [États-Unis] ; Joseph Conigliaro [États-Unis]Examination of patient characteristics and hydroxychloroquine use based on the US Food and Drug Administration's recommendation: a cross-sectional analysis in New York.
000559 (2021) Kamer Tecen-Yucel [Turquie] ; Elif Aras-Atik [Turquie] ; Aygin Bayraktar-Ekincioglu [Turquie]Does therapeutic drug monitoring of hydroxychloroquine improve treatment outcome in intensive care unit patients with COVID-19?
000610 (2021) Majid Mokhtari [Iran] ; Minoo Mohraz [Iran] ; Mohammad Mehdi Gouya [Iran] ; Hengameh Namdari Tabar [Iran] ; Jafar-Sadegh Tabrizi [Iran] ; Katayoun Tayeri [Iran] ; Saeide Aghamohamadi [Iran] ; Zahra Rajabpoor [Iran] ; Manoochehr Karami [Iran] ; Alireza Raeisi [Iran] ; Hamid Rahmani [Iran] ; Hossein Khalili [Iran]Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting.
000614 (2021) Gabriel Stefan [Roumanie] ; Ana Maria Mehedinti [Roumanie] ; Iuliana Andreiana [Roumanie] ; Adrian Dorin Zugravu [Roumanie] ; Simona Cinca [Roumanie] ; Ruxandra Busuioc [Roumanie] ; Ioana Miler [Roumanie] ; Simona Stancu [Roumanie] ; Ligia Petrescu [Roumanie] ; Ioana Dimitriu [Roumanie] ; Elena Moldovanu [Roumanie] ; Diana Elena Crasnaru [Roumanie] ; Georgeta Gugonea [Roumanie] ; Valentin Georgescu [Roumanie] ; Victor Dan Strambu [Roumanie] ; Cristina Capusa [Roumanie]Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania.
000616 (2021) Rosemarie De Souza [Oman] ; Sharayu Mhatre [Inde] ; Burhanuddin Qayyumi [Inde] ; Garvit Chitkara [Inde] ; Tushar Madke [Inde] ; Mohan Joshi [Inde] ; Ramesh Bharmal [Inde] ; D S Asgaonkar [Inde] ; Prem Lakhani [Inde] ; Sudeep Gupta [Inde] ; Pankaj Chaturvedi [Inde] ; Rajesh Dikshit [Inde] ; Rajendra Badwe [Inde]Clinical course and outcome of patients with COVID-19 in Mumbai City: an observational study.
000619 (2021) Zeyad A. Alzahrani [Arabie saoudite] ; Khalid Abdullah Alghamdi [Arabie saoudite] ; Ahmed Saeed Almaqati [Arabie saoudite]Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases.
000623 (2021) Pedro Salvador ; Pedro Oliveira ; Tiago Costa ; Mariana Fidalgo ; Raul Neto ; Maria Leonor Silva ; Crist Vão Figueiredo ; Vera Afreixo ; Tiago Greg Rio ; Luís MalheiroClinical Features and Prognostic Factors of 245 Portuguese Patients Hospitalized With COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "outcome" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "outcome" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    outcome
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021